Form 4 for GILD Gilead Sciences
Accepted 2022-03-14 00:00:00 ET · period of report 2022-03-10 · accession 0001127602-22-009215 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-14 | 2022-03-10 | GILD | Pletcher Brett A | EVP, Corp Affairs, Gen Counsel | M - OptEx | — | +5,723 | 38.3K | +18% | — |
| D | 2022-03-14 | 2022-03-11 | GILD | Pletcher Brett A | EVP, Corp Affairs, Gen Counsel | S - Sale+OE | $58.24 | -3,634 | 32.6K | -10% | -$211.6K |
| D | 2022-03-14 | 2022-03-10 | GILD | Pletcher Brett A | EVP, Corp Affairs, Gen Counsel | F - Tax | $57.92 | -2,089 | 36.2K | -5% | -$121.0K |
| DM | 2022-03-14 | 2022-03-10 | GILD | Pletcher Brett A | EVP, Corp Affairs, Gen Counsel | M - OptEx | — | -5,723 | 20.4K | -22% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-10 | M | A | 2,593 | — | 35,169 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2022-03-11 | S | D | 3,634 | $58.24 | 32,576 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-10 | F | D | 2,089 | $57.92 | 36,210 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-10 | M | A | 3,130 | — | 38,299 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 5 | Derivative | Restricted Stock Unit | 2022-03-10 | M | D | 3,130 | — | 17,301 | D | — · — to — | 3,130 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 6 | Derivative | Restricted Stock Unit | 2022-03-10 | M | D | 2,593 | — | 20,431 | D | — · — to — | 2,593 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested. |